Rex1 (Zfp-42) is a known marker of pluripotency, and is usually found in undifferentiated embryonic stem cells. In addition to being a marker for pluripotency, its regulation is also critical in maintaining a pluripotent state. As the cells begin to differentiate, Rex1 is severely and abruptly downregulated. During embryogenesis, the inner cell mass (ICM) is separated from the trophoblast. The stem cells derived from the ICM and trophectoderm have been found to express high levels of Oct3/4 and Rex1. As the ICM matures and begins to form the epiblast, and primitive ectoderm, the cells in the ICM have been found to be a heterogenous population, with varying levels of Rex1 expression. Rex1−/Oct3/4− triggers trophectoderm differentiation, while Rex1+/Oct3/4+ cells predominantly differentiate into primitive endoderm and mesoderm. Also, Rex1−/Oct3/4+ cells differentiate into cells of primitive ectoderm, the somatic cell lineage. Studies have shown that PEG3 and Nespas are downstream targets of Rex1. Rex1 can control the expression of Peg3 via epigenetic changes. YY1 has been shown to be involved in setting up DNA methylation on the maternal allele of PEG3 during oogenesis. Rex1 was found to protect the paternal allele from being methylated, and keep the PEG3 gene unmethylated during early embryogenesis. Rex1 exhibits gene control in developing embryos via its epigenetic control on genes such as PEG3, which has been identified as playing a key role in fetal growth rates. The only adult tissue Rex1 has been identified in are the testicles. Using in situ hybridization it was determined that the spermatocytes in the more inner layers of the testicles are expressing Rex1. Thus, the male germ cells undergoing meiosis are the specific cells in the testicles that express Rex1. It has not been observed, however, that Rex1 is expressed in the female germ cells.
Background References
1. Mongan N.P., Martin K.M., Gudas L.J.; "The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures."; Mol. Carcinog. 45:887-900(2006).
2. Raman J.D., Mongan N.P., Liu L., Tickoo S.K., Nanus D.M., Scherr D.S., Gudas L.J.; "Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma."; Carcinogenesis 27:499-507(2006).
Sequence Similarity
Belongs to the krueppel C2H2-type zinc-finger protein family.
Tissue Specificity
Expressed in kidney, epidermal keratinocytes, prostate epithelial cells, bronchial and small airway lung epithelial cells (at protein level). Expressed in malignant kidney and several carcinoma cell lines (at protein level). Expressed in embryonic stem cells, kidney, epidermal keratinocytes, prostate epithelial cells, bronchial and small airway lung epithelial cells. Expressed in embryonal carcinomas, seminomas, malignant kidney and several carcinoma cell lines.
Post-translational Modification
Polyubiquitinated by RNF12, leading to proteasomal degradation.
Western blot analysis of ZFP-42/REX-1 on Raji (Human Burkitt's lymphoma cell) lysates with Rabbit anti-ZFP-42/REX-1 antibody (0731-2) at 1/5,000 dilution.
Lysates/proteins at 15 µg/Lane. Exposure time: 3 minutess; ECL: K1801
Blocking: 5% NFDM/TBST, 1 hour at room temperature Primary antibody: 0731-2, 1/5,000 in primary antibody dilution buffer (K1803), overnight at 4 ℃ Secondary antibody: Goat anti-Rabbit IgG-HRP (HA1001), 1/50,000 in 5% NFDM/TBST, 1 hour at room temperature
Predicted band size: 35 kDa Observed band size: 47 kDa
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"